| Lisa J Heller, MD | |
|
950 Haverfor Rd, Ste 107, Bryn Mawr, PA 19010 | |
| (610) 527-4715 | |
| (610) 527-3649 |
| Full Name | Lisa J Heller |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 950 Haverfor Rd, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245267145 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD040369E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lisa J Heller, MD 950 Haverfor Rd, Ste 107, Bryn Mawr, PA 19010 Ph: (610) 527-4715 | Lisa J Heller, MD 950 Haverfor Rd, Ste 107, Bryn Mawr, PA 19010 Ph: (610) 527-4715 |
News Archive
BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
Even super heroes need a chance to get better, especially if they've been fighting their arch-nemesis and a robotic crab that just won't go away. At least, that's the premise behind a video game developed at the University of Utah to help children with cancer during their treatment.
Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, today announced that the U.S. Patent & Trademark Office has issued U.S. Patent 7,842,683 entitled, "Neurotherapeutic Compositions and Methods."
US Oncology, Inc., the nation's leading integrated oncology company, announced today that it has enrolled the 1,000th patient in a Phase I clinical trial through its US Oncology Research Network. Phase I clinical trials present special challenges, including increased safety concerns, higher variability of patient disease, more complex trial designs, and some first-in-human trials, making Phase I trials more difficult to operate in the community setting.
Celator Pharmaceuticals today announced that Scott Jackson, chief executive officer, is scheduled to present at the Thomas Weisel Partners 2009 Healthcare Conference in Boston.
› Verified 1 days ago
Dr. Cheri Korb, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 484-337-3000 | |
Dr. Thanh G Kirkpatrick, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 130 S. Bryn Mawr Ave., Bryn Mawr, PA 19010 Phone: 610-526-3000 Fax: 302-651-5938 | |
Karla Swatski, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 864 County Line Rd, Bryn Mawr, PA 19010 Phone: 610-525-0560 Fax: 610-527-8683 | |
Dr. Ryan Michael Mascio, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 663 W Lancaster Ave, Bryn Mawr, PA 19010 Phone: 610-658-0999 | |
Dr. Scott Michael Pugh, MD, FAAP Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 919 Conestoga Rd, Bldg. 3, Suite 111, Bryn Mawr, PA 19010 Phone: 610-527-4715 | |
Dr. Wenonah Lynne Huston Nelson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 864 County Line Rd, Bryn Mawr, PA 19010 Phone: 610-525-0560 Fax: 610-527-8683 | |
Dr. Sandra Grossman, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 610-526-3000 |